The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Fabry Disease Treatment Market Research Report 2025
Synopsis
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
The global Fabry Disease Treatment market was valued at US$ 1532.2 million in 2023 and is anticipated to reach US$ 2288.3 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fabry Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fabry Disease Treatment.
Report Scope
The Fabry Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fabry Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fabry Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi S.A.
Takeda
Amicus Therapeutics Inc.
ISU Abxis Co Ltd.
JCR Pharmaceuticals Co Ltd.
Protalix Biotherapeutics Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
Greenovation Biotech GmbH
Moderna Therapeutics Inc.
Green Cross Pharma Pte Ltd.
Segment by Type
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fabry Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
The global Fabry Disease Treatment market was valued at US$ 1532.2 million in 2023 and is anticipated to reach US$ 2288.3 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Fabry Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fabry Disease Treatment.
Report Scope
The Fabry Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fabry Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fabry Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi S.A.
Takeda
Amicus Therapeutics Inc.
ISU Abxis Co Ltd.
JCR Pharmaceuticals Co Ltd.
Protalix Biotherapeutics Inc.
Idorsia Pharmaceuticals Ltd.
Avrobio Inc.
Greenovation Biotech GmbH
Moderna Therapeutics Inc.
Green Cross Pharma Pte Ltd.
Segment by Type
Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fabry Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fabry Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enzyme Replacement Therapy (ERT)
1.2.3 Chaperone Treatment
1.2.4 Substrate Reduction Therapy (SRT)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fabry Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fabry Disease Treatment Market Perspective (2019-2030)
2.2 Fabry Disease Treatment Growth Trends by Region
2.2.1 Global Fabry Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Fabry Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Fabry Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Fabry Disease Treatment Market Dynamics
2.3.1 Fabry Disease Treatment Industry Trends
2.3.2 Fabry Disease Treatment Market Drivers
2.3.3 Fabry Disease Treatment Market Challenges
2.3.4 Fabry Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fabry Disease Treatment Players by Revenue
3.1.1 Global Top Fabry Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fabry Disease Treatment Revenue
3.4 Global Fabry Disease Treatment Market Concentration Ratio
3.4.1 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Treatment Revenue in 2023
3.5 Fabry Disease Treatment Key Players Head office and Area Served
3.6 Key Players Fabry Disease Treatment Product Solution and Service
3.7 Date of Enter into Fabry Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fabry Disease Treatment Breakdown Data by Type
4.1 Global Fabry Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Fabry Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Fabry Disease Treatment Breakdown Data by Application
5.1 Global Fabry Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Fabry Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Fabry Disease Treatment Market Size (2019-2030)
6.2 North America Fabry Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Fabry Disease Treatment Market Size by Country (2019-2024)
6.4 North America Fabry Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fabry Disease Treatment Market Size (2019-2030)
7.2 Europe Fabry Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Fabry Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Fabry Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fabry Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Fabry Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Fabry Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Fabry Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fabry Disease Treatment Market Size (2019-2030)
9.2 Latin America Fabry Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Fabry Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Fabry Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fabry Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Fabry Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Fabry Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Fabry Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Detail
11.1.2 Sanofi S.A. Business Overview
11.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
11.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2019-2024)
11.1.5 Sanofi S.A. Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Fabry Disease Treatment Introduction
11.2.4 Takeda Revenue in Fabry Disease Treatment Business (2019-2024)
11.2.5 Takeda Recent Development
11.3 Amicus Therapeutics Inc.
11.3.1 Amicus Therapeutics Inc. Company Detail
11.3.2 Amicus Therapeutics Inc. Business Overview
11.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
11.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.3.5 Amicus Therapeutics Inc. Recent Development
11.4 ISU Abxis Co Ltd.
11.4.1 ISU Abxis Co Ltd. Company Detail
11.4.2 ISU Abxis Co Ltd. Business Overview
11.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
11.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.4.5 ISU Abxis Co Ltd. Recent Development
11.5 JCR Pharmaceuticals Co Ltd.
11.5.1 JCR Pharmaceuticals Co Ltd. Company Detail
11.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
11.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
11.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
11.6 Protalix Biotherapeutics Inc.
11.6.1 Protalix Biotherapeutics Inc. Company Detail
11.6.2 Protalix Biotherapeutics Inc. Business Overview
11.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
11.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.6.5 Protalix Biotherapeutics Inc. Recent Development
11.7 Idorsia Pharmaceuticals Ltd.
11.7.1 Idorsia Pharmaceuticals Ltd. Company Detail
11.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
11.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
11.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
11.8 Avrobio Inc.
11.8.1 Avrobio Inc. Company Detail
11.8.2 Avrobio Inc. Business Overview
11.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
11.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.8.5 Avrobio Inc. Recent Development
11.9 Greenovation Biotech GmbH
11.9.1 Greenovation Biotech GmbH Company Detail
11.9.2 Greenovation Biotech GmbH Business Overview
11.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
11.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2019-2024)
11.9.5 Greenovation Biotech GmbH Recent Development
11.10 Moderna Therapeutics Inc.
11.10.1 Moderna Therapeutics Inc. Company Detail
11.10.2 Moderna Therapeutics Inc. Business Overview
11.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
11.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024)
11.10.5 Moderna Therapeutics Inc. Recent Development
11.11 Green Cross Pharma Pte Ltd.
11.11.1 Green Cross Pharma Pte Ltd. Company Detail
11.11.2 Green Cross Pharma Pte Ltd. Business Overview
11.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
11.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2019-2024)
11.11.5 Green Cross Pharma Pte Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Fabry Disease Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enzyme Replacement Therapy (ERT)
Table 3. Key Players of Chaperone Treatment
Table 4. Key Players of Substrate Reduction Therapy (SRT)
Table 5. Key Players of Others
Table 6. Global Fabry Disease Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Fabry Disease Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Fabry Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Fabry Disease Treatment Market Share by Region (2019-2024)
Table 10. Global Fabry Disease Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Fabry Disease Treatment Market Share by Region (2025-2030)
Table 12. Fabry Disease Treatment Market Trends
Table 13. Fabry Disease Treatment Market Drivers
Table 14. Fabry Disease Treatment Market Challenges
Table 15. Fabry Disease Treatment Market Restraints
Table 16. Global Fabry Disease Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Fabry Disease Treatment Market Share by Players (2019-2024)
Table 18. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Treatment as of 2023)
Table 19. Ranking of Global Top Fabry Disease Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Fabry Disease Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Fabry Disease Treatment Product Solution and Service
Table 23. Date of Enter into Fabry Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fabry Disease Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Fabry Disease Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Fabry Disease Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Fabry Disease Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Fabry Disease Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Fabry Disease Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Fabry Disease Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Fabry Disease Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Fabry Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Fabry Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Fabry Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Fabry Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Fabry Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Fabry Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Fabry Disease Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Fabry Disease Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Fabry Disease Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Fabry Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Fabry Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Fabry Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Fabry Disease Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Fabry Disease Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Fabry Disease Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Sanofi S.A. Company Detail
Table 49. Sanofi S.A. Business Overview
Table 50. Sanofi S.A. Fabry Disease Treatment Product
Table 51. Sanofi S.A. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 52. Sanofi S.A. Recent Development
Table 53. Takeda Company Detail
Table 54. Takeda Business Overview
Table 55. Takeda Fabry Disease Treatment Product
Table 56. Takeda Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 57. Takeda Recent Development
Table 58. Amicus Therapeutics Inc. Company Detail
Table 59. Amicus Therapeutics Inc. Business Overview
Table 60. Amicus Therapeutics Inc. Fabry Disease Treatment Product
Table 61. Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 62. Amicus Therapeutics Inc. Recent Development
Table 63. ISU Abxis Co Ltd. Company Detail
Table 64. ISU Abxis Co Ltd. Business Overview
Table 65. ISU Abxis Co Ltd. Fabry Disease Treatment Product
Table 66. ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 67. ISU Abxis Co Ltd. Recent Development
Table 68. JCR Pharmaceuticals Co Ltd. Company Detail
Table 69. JCR Pharmaceuticals Co Ltd. Business Overview
Table 70. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product
Table 71. JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 72. JCR Pharmaceuticals Co Ltd. Recent Development
Table 73. Protalix Biotherapeutics Inc. Company Detail
Table 74. Protalix Biotherapeutics Inc. Business Overview
Table 75. Protalix Biotherapeutics Inc. Fabry Disease Treatment Product
Table 76. Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 77. Protalix Biotherapeutics Inc. Recent Development
Table 78. Idorsia Pharmaceuticals Ltd. Company Detail
Table 79. Idorsia Pharmaceuticals Ltd. Business Overview
Table 80. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product
Table 81. Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 82. Idorsia Pharmaceuticals Ltd. Recent Development
Table 83. Avrobio Inc. Company Detail
Table 84. Avrobio Inc. Business Overview
Table 85. Avrobio Inc. Fabry Disease Treatment Product
Table 86. Avrobio Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 87. Avrobio Inc. Recent Development
Table 88. Greenovation Biotech GmbH Company Detail
Table 89. Greenovation Biotech GmbH Business Overview
Table 90. Greenovation Biotech GmbH Fabry Disease Treatment Product
Table 91. Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 92. Greenovation Biotech GmbH Recent Development
Table 93. Moderna Therapeutics Inc. Company Detail
Table 94. Moderna Therapeutics Inc. Business Overview
Table 95. Moderna Therapeutics Inc. Fabry Disease Treatment Product
Table 96. Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 97. Moderna Therapeutics Inc. Recent Development
Table 98. Green Cross Pharma Pte Ltd. Company Detail
Table 99. Green Cross Pharma Pte Ltd. Business Overview
Table 100. Green Cross Pharma Pte Ltd. Fabry Disease Treatment Product
Table 101. Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2019-2024) & (US$ Million)
Table 102. Green Cross Pharma Pte Ltd. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fabry Disease Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Fabry Disease Treatment Market Share by Type: 2023 VS 2030
Figure 3. Enzyme Replacement Therapy (ERT) Features
Figure 4. Chaperone Treatment Features
Figure 5. Substrate Reduction Therapy (SRT) Features
Figure 6. Others Features
Figure 7. Global Fabry Disease Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Fabry Disease Treatment Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Fabry Disease Treatment Report Years Considered
Figure 13. Global Fabry Disease Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Fabry Disease Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Fabry Disease Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Fabry Disease Treatment Market Share by Players in 2023
Figure 17. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Fabry Disease Treatment Revenue in 2023
Figure 19. North America Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Fabry Disease Treatment Market Share by Country (2019-2030)
Figure 21. United States Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Fabry Disease Treatment Market Share by Country (2019-2030)
Figure 25. Germany Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Fabry Disease Treatment Market Share by Region (2019-2030)
Figure 33. China Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Fabry Disease Treatment Market Share by Country (2019-2030)
Figure 41. Mexico Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Fabry Disease Treatment Market Share by Country (2019-2030)
Figure 45. Turkey Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Fabry Disease Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Sanofi S.A. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 48. Takeda Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 49. Amicus Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 50. ISU Abxis Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 51. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 52. Protalix Biotherapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 53. Idorsia Pharmaceuticals Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 54. Avrobio Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 55. Greenovation Biotech GmbH Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 56. Moderna Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 57. Green Cross Pharma Pte Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
